JANE STREET GROUP, LLC - 10X GENOMICS INC ownership

10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 341 filers reported holding 10X GENOMICS INC in Q2 2021. The put-call ratio across all filers is 0.17 and the average weighting 1.1%.

Quarter-by-quarter ownership
JANE STREET GROUP, LLC ownership history of 10X GENOMICS INC
ValueSharesWeighting
Q3 2023$862,249
-77.9%
20,903
-70.1%
0.00%
-100.0%
Q2 2023$3,904,053
+14.1%
69,915
+14.0%
0.00%0.0%
Q1 2023$3,420,541
+38.4%
61,311
-9.6%
0.00%0.0%
Q4 2022$2,471,689
+247.1%
67,829
+171.2%
0.00%
Q3 2022$712,000
-49.2%
25,013
-19.3%
0.00%
-100.0%
Q2 2022$1,402,000
-74.0%
30,986
-56.2%
0.00%0.0%
Q1 2022$5,386,000
+4.1%
70,800
+103.8%
0.00%
-50.0%
Q4 2021$5,174,000
-41.8%
34,733
-43.1%
0.00%
-33.3%
Q3 2021$8,886,000
-60.3%
61,031
-46.7%
0.00%
-62.5%
Q2 2021$22,408,000
+15.8%
114,431
+7.0%
0.01%
-11.1%
Q1 2021$19,353,000
+248.8%
106,917
+172.9%
0.01%
+200.0%
Q4 2020$5,548,000
-74.7%
39,178
-77.7%
0.00%
-76.9%
Q3 2020$21,907,000
+339.2%
175,704
+214.6%
0.01%
+225.0%
Q2 2020$4,988,000
+109.1%
55,848
+45.9%
0.00%
+100.0%
Q1 2020$2,385,000
+371.3%
38,266
+280.9%
0.00%
+100.0%
Q3 2019$506,00010,0470.00%
Other shareholders
10X GENOMICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
Foresite Capital Management II, LLC 1,358,528$49,504,760100.00%
Meritech Capital Associates V L.L.C. 1,061,682$38,687,6929.44%
Decheng Capital Management III (Cayman), LLC 359,554$13,102,1484.90%
Sands Capital Ventures, LLC 481,770$17,5564.81%
Whitford Management LLC 58,310$2,124,8032.88%
FINANCIAL CONSULATE, INC 156,457$5,701,2931.99%
SRS Investment Management, LLC 3,005,427$109,517,7601.98%
BRANDYWINE MANAGERS, LLC 11,208$408,4201.43%
ARK Investment Management 4,316,567$157,295,7011.36%
Nikko Asset Management Americas, Inc. 2,177,988$79,365,8831.14%
View complete list of 10X GENOMICS INC shareholders